(2S,4R)-1-(tert-Butoxycarbonyl)-4-methoxypyrrolidine-2-carboxylic acid, 95%, 250mg

1,2-BENZISOTHIAZOL-3(2H)-ONE, 5-NITRO-, 1,1-DIOXIDE, 95.0%, 1g

2,3,4,5-Tetrachloronitrobenzene, 97.0%, 1g

ethyl 5-(2,6-difluorophenyl)-5-oxovalerate, 97.0%, 1g

Bolsas de muestra ROTILABO® con área de rotulación, 40 mm, Altura, 60 mm, 100 Unidad(es)

2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one, 97.0%, 10g

Methyl 2-(4-bromo-6-methylpyridin-2-yl)acetate, 95%, 1g

tert-Butyl 3-(2-oxoethyl)azetidine-1-carboxylate, 95.0%, 25g

2-AMINO-5-BROMOTHIAZOLE-4-CARBONITRILE, 95.0%, 100mg

6'-(Diethylamino)-1',2'-benzofluoran>98.0%(GC)(T)25g

(6-Chloro-2-methoxypyridin-3-yl)methanamine, 97%, 100mg

3-(Pyridin-4-yl)propan-1-ol, 97.0%, 100g

Propanoic acid, 3,3'-[1,2-ethanediylbis(oxy)]bis-, 98%, 1g